Gower, Brad L.,Park, Jae Han,Herman, Clifford J.,Lai, Tsz Chung,Feng, Kai
申请号：
AU2017216904
公开号：
AU2017216904A1
申请日:
2017.01.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.
